A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
As used in this Report, each of the terms “we,” “us,” “our,” the “Company,” and “Simulations Plus” refers to Simulations Plus, Inc. and its wholly owned subsidiaries (both current and previous, as applicable). Simulations Plus, Inc. was incorporated in California on July 17, 1996. The Company is a global leader and premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery and development, clinical trial operations, and commercialization. The Company supports its clients across the drug development lifecycle from early discovery through all phases of clinical research and development (“R&D”), including clinical operations, to product commercialization. The Company serves clients as a strategic partner throughout the entire drug development lifecycle, offering solutions that integrate scientific software platforms, artificial intelligence-augmented insights, and expert consulting.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 79M | 79M | 70M | 60M | 54M | 46M |
| Net Income | -64M | -65M | 10.0M | 10.0M | 12M | 9.8M |
| EPS | $-3.20 | $-3.22 | $0.49 | $0.49 | $0.60 | $0.47 |
| Free Cash Flow | 0 | 17M | 13M | 21M | 17M | 18M |
| ROIC | -60.6% | -51.9% | 3.0% | 13.6% | 24.6% | 23.5% |
| Gross Margin | 59.6% | 58.4% | 61.6% | 80.5% | 79.9% | 77.2% |
| Debt/Equity | 0.00 | 0.06 | 0.08 | 0.09 | 0.06 | 0.09 |
| Dividends/Share | $0.00 | - | $0.24 | $0.24 | $0.23 | $0.23 |
| Operating Income | -70M | -71M | 6.1M | 8.7M | 15M | 11M |
| Operating Margin | -89.2% | -89.3% | 8.8% | 14.6% | 27.7% | 24.2% |
| ROE | -50.5% | -42.1% | 5.5% | 5.9% | 7.0% | 5.9% |
| Shares Outstanding | 20M | 20M | 20M | 20M | 21M | 21M |
Simulations Plus, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 15.5x vs a median of 43.1x. The company's 5-year average ROIC is 2.6% with a gross margin of 71.5%. At current prices, the estimated annualized return to fair value is +6.6%.
Simulations Plus, Inc. (SLP) has a 5-year average return on invested capital (ROIC) of 2.6%. This is below average and may indicate limited pricing power.
Simulations Plus, Inc. (SLP) has a market capitalization of $269M. It is classified as a small-cap stock.
Simulations Plus, Inc. (SLP) does not currently pay a regular dividend.
Simulations Plus, Inc. (SLP) operates in the Services-Computer Integrated Systems Design industry, within the Technology sector.
Simulations Plus, Inc. (SLP) reported annual revenue of $79 million in its most recent fiscal year, based on SEC EDGAR filings.
Simulations Plus, Inc. (SLP) has a net profit margin of -81.7%. The company is currently unprofitable.
Simulations Plus, Inc. (SLP) generated $17 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Simulations Plus, Inc. (SLP) has a debt-to-equity ratio of 0.06. This indicates a conservatively financed balance sheet.
Simulations Plus, Inc. (SLP) reported earnings per share (EPS) of $-3.22 in its most recent fiscal year.
Simulations Plus, Inc. (SLP) has a return on equity (ROE) of -42.1%. A negative ROE may indicate losses or negative equity.
Simulations Plus, Inc. (SLP) has a 5-year average gross margin of 71.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for Simulations Plus, Inc. (SLP), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Simulations Plus, Inc. (SLP) has a book value per share of $6.21, based on its most recent annual SEC filing.